Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vaxcyte Inc. Common Stock (PCVX) vs W.R. Berkley Corporation Common Stock (WRB) Price & Performance

Vaxcyte Inc. Common StockTrade
W.R. Berkley Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Vaxcyte Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while W.R. Berkley Corporation Common Stock trades at $74.25 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 2.6× Vaxcyte Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.

PCVXWRB
Market Cap
$10.51B$27.30B
Volume
2,644,6942,293,079
Sector
HealthFinancials
52-Week High
$73.82$78.10
52-Week Low
$40.32$63.54
Typical Hold Time
0 Days0 Days
Enterprise Value
$9.14B$27.54B
Dividend Yield
—0.54%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PCVX
100% Buy0% Sell
Avg holding period · 0 Days
WRB
100% Buy0% Sell
Avg holding period · 0 Days

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →

About W.R. Berkley Corporation Common Stock

W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.

Read more on WRB →